Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Materials
  • References
  • Reprints and Permissions

Summary

This article describes the isolation of mouse aortic valve cells by a two-step collagenase procedure. Isolated mouse valve cells are important for performing different assays, such as this in vitro calcification assay, and for investigating the molecular pathways leading to aortic valve mineralization.

Abstract

The calcification of aortic valve cells is the hallmark of aortic stenosis and is associated with valve cusp fibrosis. Valve interstitial cells (VICs) play an important role in the calcification process in aortic stenosis through the activation of their dedifferentiation program to osteoblast-like cells. Mouse VICs are a good in vitro tool for the elucidation of the signaling pathways driving the mineralization of the aortic valve cell. The method described herein, successfully used by these authors, explains how to obtain freshly isolated cells. A two-step collagenase procedure was performed with 1 mg/mL and 4.5 mg/mL. The first step is crucial to remove the endothelial cell layer and avoid any contamination. The second collagenase incubation is to facilitate the migration of VICs from the tissue to the plate. In addition, an immunofluorescence staining procedure for the phenotype characterization of the isolated mouse valve cells is discussed. Furthermore, the calcification assay was performed in vitro by using the calcium reagent measurement procedure and alizarin red staining. The use of mouse valve cell primary culture is essential for testing new pharmacological targets to inhibit cell mineralization in vitro.

Introduction

Calcified aortic valve disease (CAVD) is the most prevalent valvular heart disease in western populations, affecting nearly 2.5% of elderly individuals over 65 years of age1. CAVD affects over six million Americans and is associated with changes in the mechanical properties of the leaflets that impair normal blood flow-through1,2. Currently, there is no pharmacological treatment to stop the progression of the disease or to activate mineral regression. The only effective therapy to treat CAVD is aortic valve replacement by surgery or transcatheter aortic valve replacement

Protocol

NOTE: All animal procedures described here have been approved by Icahn School of Medicine at Mount Sinai institutional core and use committee.

1. Preparation before valve cell isolation from adult mice

  1. Clean and sterilize all the surgical instruments shown in Figure 1A by using 70% v/v ethanol and subsequently autoclaving them for 30 min. clean the surgical workspace with 70% ethanol.
  2. Add 500 µL of penicillin-streptomycin to 50 mL of 10 mm HEPES. Prepare an aliquot of 50 mL of 1x phosphate-buffered saline (PBS). Keep the solutions on ice.
  3. Prepare 1 mg/mL and 4.5 mg/mL collag....

Representative Results

As murine aortic valves are typically 1 mm in diameter, at least three valves must be pooled to collect a million viable cells for different experimental procedures. The different steps of the VIC isolation process are shown in Figure 1 and Figure 2. As it is difficult to manually scrape the valve tissue, it is preferable to use shear stress created by vortexing to remove the VECs. Indeed, the CD31 immunofluorescence staining results showed the absence of endoth.......

Discussion

This article presents a detailed protocol of mouse valve cell isolation for primary culture. Three aortic valves from 8-week-old mice were pooled to obtain an adequate number of cells. In addition, this protocol describes the characterization of VIC phenotype and the in vitro mineralization assay. The method was adapted from the previously described protocol from Mathieu et al.7.

During the isolation of aortic valves, care must be taken to avoid all so.......

Materials

NameCompanyCatalog NumberComments
3 mm cutting edge scissorsF.S.T15000-00
Anti-alpha smooth muscle Actin antibodyabcam
Anti-mouse, Alexa Fluor 488 conjugateCell Signaling4412
Arsenazo-III reagent setPOINT SCIENTIFICC7529-500a Kit to measure the concentration of calcium
Bonn ScissorsF.S.T14184-09
Calcium hydroxideSIGMA -Aldrich 3121931219
CD31Novusbio
Collagenase type I  (125 units/mg)Thermofisher Scientific17018029
DMEMTthermofisher11965092
Extra fine graefe forcepsF.S.T11150-10
FBSGibco 16000044
Fine forcepsF.S.T Dumont
HClSIGMA-ALDRICHH1758
HEPES 1 M solutionSTEMCELLS TECHNOLOGIES
L-Glutamine 100xThermofisher Scientific25030081
MycozapLanzaVZA-2011Mycoplasma elimination reagent
PBS 10xSIGMA-ALDRICH
penecillin streptomycin 100xThermofisher Scientific10378016
Sodium Pyruvate 100 mMThermofisher Scientific11360070
Standard pattern forceps F.S.T11000-12
Surgical Scissors - Sharp-BluntF.S.T14008-14
Trypsin 0.05%Thermofisher Scientific25300054
Vimentinabcam

References

  1. Rostagno, C. Heart valve disease in elderly. World Journal of Cardiology. 11 (2), 71-83 (2019).
  2. Stewart, B. F., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Mouse Interstitial Valve CellsAortic Valve CalcificationIn VitroTwo step DigestionAortic Valve IsolationCollagenaseHEPESCell CultureCell SeparationCentrifugation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved